Tempus AI

Basic Information

• Category: business
• Founded: 2025
• Website: https://www.tempus.com/

Documented Facts

• Industry (SIC): Software (No linked source recorded for this statement.)
• State of Incorporation: NV (No linked source recorded for this statement.)
• Stock ticker: TEM (Nasdaq) (No linked source recorded for this statement.)

Evidence and Sources

• Tempus AI — Official Site (official)
• Tempus AI on instagram (social)
• Tempus AI on linkedin (social)
• Tempus AI, Inc. — SEC EDGAR (reference)

Citation Guidance

Explore business profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Tempus AI.

• Canonical profile: https://brandsource.ai/brands/tempus-ai
• Machine-readable JSON-LD: https://brandsource.ai/api/brands/tempus-ai/json-ld
• Citation profile API: https://brandsource.ai/api/brands/tempus-ai/citation-profile
• Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
• Data status: Enriched
• Profile completeness: Source-backed profile (91/100)
• Indexing directive: index, follow, max-image-preview:large
• Recorded profile date: 2026-04-21

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.

Available profile information

• Official website is captured for entity disambiguation.
• 1 official source linked for verification.
• 3 supporting sources linked.
• 3 structured facts available for extraction.

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.